P68

Autor: E. Grigorieva, M. Karbyshev, V. Volkomorov, E. Kremmer, A. Huber, I. Mitrofanova, M. Zavyalova, E. Kaigorodova, J. Kzhyshkowska, N. Cherdyntseva

Publikováno v: EJC Supplements, Vol 13, Iss 1, Pp 18-19 (2015)

Transmembrane prostate androgen-induced protein 1 (TMEPAI) is a membrane protein that has attracted significant attention of many researchers its involvement in TGF-β signaling pathway which involved in malignant transformation and metastatic tumor

Externí odkaz: https://doaj.org/article/18f148e37e034685ba693c412320db82

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Nucleic Acids Res

Autor: H. C. Eberl, Jens Michaelis, S. M. Wiedemann, Clemens Bönisch, J. Neumann, Sebastian Pünzeler, C. Bielmeier, W. Kuegel, Heinrich Leonhardt, E. Kremmer, Marco Bocola, Katrin Schneider, Matthias Mann, Lothar Schermelleh, Sandra B. Hake

Publikováno v: Nucleic Acids Res. 40, 5951-5964 (2012)
Nucleic Acids Research

The histone variant H2A.Z has been implicated in many biological processes, such as gene regulation and genome stability. Here, we present the identification of H2A.Z.2.2 (Z.2.2), a novel alternatively spliced variant of histone H2A.Z and provide a c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6912e518c57369f7bc1ee43ad229e027
https://doi.org/10.1093/nar/gks267

Cerebral Proteomic Changes in the rTg-D Rat Model of Cerebral Amyloid Angiopathy Type-2 With Cortical Microhemorrhages and Cognitive Impairments.

Autor: Schrader, Joseph M^1,2 (AUTHOR), Majchrzak, Mark^1,2 (AUTHOR), Xu, Feng^1,2 (AUTHOR), Lee, Hedok³ (AUTHOR), Agostinucci, Kevin^1,2 (AUTHOR), Davis, Judianne^1,2 (AUTHOR), Benveniste, Helene³ (AUTHOR), Van Nostrand, William E^1,2 (AUTHOR) wvannostrand@uri.edu

Publikováno v: Neuroscience Insights. 10/8/2024, p1-14. 14p.

Targeting BRIX1 via Engineered Exosomes Induces Nucleolar Stress to Suppress Cancer Progression.

Autor: Gan Y; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China., Hao Q; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China., Han T; Institutes of Health Central Plains, Xinxiang Key laboratory for Molecular Oncology, Xinxiang Medical University, Xinxiang, Henan, 453003, P. R. China., Tong J; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China., Yan Q; Institutes of Health Central Plains, Xinxiang Key laboratory for Molecular Oncology, Xinxiang Medical University, Xinxiang, Henan, 453003, P. R. China., Zhong H; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, P. R. China.; Jiangxi Key Laboratory for Individual Cancer Therapy, Nanchang, Jiangxi, 330006, P. R. China., Gao B; Umibio Co. Ltd., Shanghai, 201210, P. R. China., Li Y; Umibio Co. Ltd., Shanghai, 201210, P. R. China., Xuan Z; Umibio Co. Ltd., Shanghai, 201210, P. R. China., Li P; Laboratory of Animal Center, Medical Experiment Center, Shaanxi University of Chinese Medicine, Xianyang, 712046, P. R. China., Yao L; Department of Breast Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, P. R. China., Xu Y; Department of Breast Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, P. R. China., Jiang YZ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China.; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, P. R. China., Shao ZM; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China.; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, P. R. China., Deng J; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, P. R. China.; Jiangxi Key Laboratory for Individual Cancer Therapy, Nanchang, Jiangxi, 330006, P. R. China., Chen J; Department of Physiology, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, 330006, P. R. China., Zhou X; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China.; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, P. R. China.; Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology), Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, P. R. China.

Publikováno v: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Oct 30, pp. e2407370. Date of Electronic Publication: 2024 Oct 30.